BRCA1 Circos: a visualisation resource for functional analysis of missense variants
Ankita Jhuraney(University of South Florida), Álvaro N.A. Monteiro(Moffitt Cancer Center), Fergus J. Couch(Mayo Clinic), Marta Santamariña Pena(Centre for Biomedical Network Research on Rare Diseases), Ana Vega(Complejo Hospitalario Universitario de Santiago), Renato S. Carvalho(Instituto Nacional do Câncer), Marinus J. Blok(Maastricht University), Tuya Pal(Vanderbilt University Medical Center), Sandrine M. Caputo(Institut Curie), Shyam K. Sharan(National Cancer Institute), Aneliya Velkova(Moffitt Cancer Center), Maaike P.G. Vreeswijk(Leiden University Medical Center), Maxime Vallée(Hospices Civils de Lyon), Talia Donenberg(University of Miami), Sean V. Tavtigian(University of Utah), Alvaro Galli(Istituto di Fisiologia Clinica), J. N. Mark Glover(University of Alberta), Randall C. Johnson(Conservatoire National des Arts et Métiers), Susan L. Neuhausen(City of Hope), Gaël A. Millot(Sorbonne Université), Marcelo A. Carvalho(Instituto Federal do Rio de Janeiro), Rob B. van der Luijt(Institute for Quality and Efficiency in Health Care), Eva Macháčková(Masaryk Memorial Cancer Institute), Lawrence C. Brody(National Institutes of Health), Phillip J Whiley(QIMR Berghofer Medical Research Institute), Simon Thomas(Smith College), Amanda B. Spurdle(QIMR Berghofer Medical Research Institute), Bailey Kessing(Frederick National Laboratory for Cancer Research), Diana Eccles(Princess Anne Hospital), Nicolas Coquelle(Centre National de la Recherche Scientifique)
Cited by 37
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
A Draft Sequence of the Rice Genome ( <i>Oryza sativa</i> L. ssp. <i>japonica</i> )
|Science|2002|2.9k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k